Original news and analysis on international IP policy
The United Nations Human Rights Council held a panel discussion yesterday to exchange views on good practices and key challenges relevant to access to medicines. The panel gave a large part of the discussion to the recent report of the United Nations Secretary General’s High-Level Panel on Access to Medicines, much to the chagrin of the European Union and the United States.
An event held at the World Trade Organization last week walked through key recommendations of the United Nations Secretary-General’s High-Level Panel on Access to Medicines, including strategies for moving some of them forward.
The United Nations Human Rights Council in Geneva this week will host a panel discussion among a notable range of experts on access to medicines and the controversial UN Secretary-General's High-Level Panel report issued last September. The panel is expected to lead to a report sent on to the Human Rights Council for possible action next autumn.
The World Trade Organization committee on intellectual property rights met this week with some discussion items that departed from past agendas but are becoming more familiar. A discussion on electronic commerce revealed interest from members, despite a slow start on details. And discussions on the United Nations High-Level Panel on Access to Medicines prompted nourished interactions and a wish by some countries to pursue the subject in future sessions.
Calling it flawed and narrow and seemingly threatened by its contents, the leading United States business group and US government IP specialists are working to limit the impact of a recent United Nations report that made recommendations for the decades-old problem of ensuring affordable medicines reach people when they are under patent in a way that does not threaten innovation. One step in countering the UN report? Change the discourse in Geneva and elsewhere.
As the World Trade Organization intellectual property committee meeting next week is expected to discuss the report of the United Nations Secretary General’s High-Level Panel on Access to Medicines next week, a group of developing countries is convening a side event to engage in discussion with members of the panel. The report included several direct recommendations to WTO members.
Multilateral institutions have received a lift with the realization of the World Trade Organization’s Trade Facilitation Agreement that is expected to provide a boost to sluggish international commerce by cutting out clogging regulations. Image Credits: Peter Kenny
Former Swiss President Ruth Dreifuss, co-chair of the United Nations Secretary General’s High-Level Panel on Access to Medicines, participated in a Geneva event on rare diseases earlier this month. She agreed to answer Intellectual Property Watch’s Catherine Saez about the High-Level Panel report, in particular how it was received by the international community, her take on criticisms that have been voiced, and the importance that the report be discussed at the international level such as the World Health Assembly.
The role of intellectual property in innovation is expected to be considered through different lenses at the upcoming meeting of the World Trade Organization committee on intellectual property. A group of developed countries have proposed an agenda item on inclusive innovation in micro, small and medium-sized enterprises, while discussions are expected on the report of the United Nations Secretary General’s High-Level Panel on Access to Medicines, and a side event featuring High-Level Panel members has been convened by a group of developing countries. Electronic commerce, and in particular copyright issues and electronic signatures are also on the agenda next week.
An interesting year lies ahead for trade policymakers. With US President Donald Trump sticking to his “America First” announcement pulling back from the Trans-Pacific Partnership right away, a new trade (world) order might be in the making. In every crisis, there is opportunity, Argentinian Trade Minister Susana Malcora said in Davos during the January World Economic Forum (WEF) where the business elite otherwise traded concerns at the beginning of an unpredictable year 2017.
A high-level meeting at the World Trade Organization today welcomed in an amendment to international trade rules for intellectual property aimed at boosting exports of affordable medicines. It also set out the way ahead to make it work.
More than a decade after World Trade Organization member states approved the first-ever legal amendment to a WTO agreement, the change to the international intellectual property agreement has entered into effect. Five more members ratified the amendment in recent days, bringing supporters over the minimum needed to put into effect the amendment aimed at boosting exports of medical products made under compulsory licence.